IP Verse

Methods And Compositions For Regulating Iron Homeostasis By Modulation Bmp-6 - EP2349332

The patent EP2349332 was granted to The General Hospital on Oct 23, 2019. The application was originally filed on Nov 13, 2009 under application number EP09826827A. The patent is currently recorded with a legal status of "Revoked".

EP2349332

THE GENERAL HOSPITAL
Application Number
EP09826827A
Filing Date
Nov 13, 2009
Status
Revoked
Mar 26, 2021
Grant Date
Oct 23, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MATHYS & SQUIREJul 23, 2020WILDINGADMISSIBLE

Patent Citations (136) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS20030419296-
DESCRIPTIONUS20050195205-
DESCRIPTIONUS20070884509-
DESCRIPTIONWO2008US59753-
DESCRIPTIONEP0404097
DESCRIPTIONUS2002155998
DESCRIPTIONUS2003077753
DESCRIPTIONUS2003082749
DESCRIPTIONUS2003143202
DESCRIPTIONUS2003215444
DESCRIPTIONUS2004009902
DESCRIPTIONUS2004071694
DESCRIPTIONUS2004091961
DESCRIPTIONUS2004143857
DESCRIPTIONUS2004157293
DESCRIPTIONUS2004175379
DESCRIPTIONUS2004175824
DESCRIPTIONUS2004229318
DESCRIPTIONUS2004248815
DESCRIPTIONUS2004266690
DESCRIPTIONUS2005019914
DESCRIPTIONUS2005020487
DESCRIPTIONUS2005026834
DESCRIPTIONUS2005096461
DESCRIPTIONUS2005107297
DESCRIPTIONUS2005107591
DESCRIPTIONUS2005124045
DESCRIPTIONUS2005124564
DESCRIPTIONUS2005137329
DESCRIPTIONUS2005142642
DESCRIPTIONUS2005143292
DESCRIPTIONUS2005153879
DESCRIPTIONUS2005158822
DESCRIPTIONUS2005158832
DESCRIPTIONUS2005170457
DESCRIPTIONUS2005181359
DESCRIPTIONUS2005181482
DESCRIPTIONUS2005192211
DESCRIPTIONUS2005202538
DESCRIPTIONUS2005227289
DESCRIPTIONUS2005244409
DESCRIPTIONUS2006040858
DESCRIPTIONUS2006088906
DESCRIPTIONUS2006111279
DESCRIPTIONUS4554101
DESCRIPTIONUS4667016
DESCRIPTIONUS4703008
DESCRIPTIONUS4816567
DESCRIPTIONUS5229275
DESCRIPTIONUS5441868
DESCRIPTIONUS5545806
DESCRIPTIONUS5545807
DESCRIPTIONUS5547933
DESCRIPTIONUS5567610
DESCRIPTIONUS5569825
DESCRIPTIONUS5571894
DESCRIPTIONUS5587458
DESCRIPTIONUS5591669
DESCRIPTIONUS5618698
DESCRIPTIONUS5621080
DESCRIPTIONUS5641870
DESCRIPTIONUS5756349
DESCRIPTIONUS5767078
DESCRIPTIONUS5773569
DESCRIPTIONUS5830851
DESCRIPTIONUS5856298
DESCRIPTIONUS5869046
DESCRIPTIONUS5955422
DESCRIPTIONUS5986047
DESCRIPTIONUS6030086
DESCRIPTIONUS6310078
DESCRIPTIONUS6391633
DESCRIPTIONUS6583272
DESCRIPTIONUS6586398
DESCRIPTIONUS6750369
DESCRIPTIONUS6824780
DESCRIPTIONUS6900292
DESCRIPTIONUS7030226
DESCRIPTIONUS7084245
DESCRIPTIONUS7217689
DESCRIPTIONWO0024893
DESCRIPTIONWO0061637
DESCRIPTIONWO0136489
DESCRIPTIONWO0181405
DESCRIPTIONWO02085940
DESCRIPTIONWO0214356
DESCRIPTIONWO0219963
DESCRIPTIONWO0220034
DESCRIPTIONWO0249673
DESCRIPTIONWO03029291
DESCRIPTIONWO03055526
DESCRIPTIONWO03084477
DESCRIPTIONWO03094858
DESCRIPTIONWO2004002417
DESCRIPTIONWO2004002424
DESCRIPTIONWO2004009627
DESCRIPTIONWO2004018667
DESCRIPTIONWO2004024761
DESCRIPTIONWO2004033651
DESCRIPTIONWO2004035603
DESCRIPTIONWO2004043382
DESCRIPTIONWO2004101600
DESCRIPTIONWO2004101606
DESCRIPTIONWO2004101611
DESCRIPTIONWO2004106373
DESCRIPTIONWO2005001025
DESCRIPTIONWO2005001136
DESCRIPTIONWO2005021579
DESCRIPTIONWO2005025606
DESCRIPTIONWO2005032460
DESCRIPTIONWO2005051327
DESCRIPTIONWO2005063808
DESCRIPTIONWO2005063809
DESCRIPTIONWO2005070451
DESCRIPTIONWO2005081687
DESCRIPTIONWO2005084711
DESCRIPTIONWO2005092369
DESCRIPTIONWO2005100403
DESCRIPTIONWO2005103076
DESCRIPTIONWO2006002646
DESCRIPTIONWO2006029094
DESCRIPTIONWO2006050959
DESCRIPTIONWO9105867
DESCRIPTIONWO9311161
DESCRIPTIONWO9316185
DESCRIPTIONWO9505465
DESCRIPTIONWO9717852
DESCRIPTIONWO9966054
INTERNATIONAL-SEARCH-REPORTUS2006239951
INTERNATIONAL-SEARCH-REPORTUS2007124825
INTERNATIONAL-SEARCH-REPORTUS2008260736
OPPOSITIONUS2003224501
OPPOSITIONUS2007032444
OPPOSITIONWO2006088972
OPPOSITIONWO2008124768
SEARCHUS2008260736

Non-Patent Literature (NPL) Citations (19) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- YIN XIA ET AL, "Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 111, no. 10, doi:10.1182/BLOOD-2007-09-111567, ISSN 0006-4971, (20080515), pages 5195 - 5204, (20080307), XP008147144
EXAMINATION- L. Kautz ET AL, "Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver", Blood, (20080513), vol. 112, no. 4, doi:10.1182/blood-2008-03-143354, ISSN 0006-4971, pages 1503 - 1509, XP055065370
OPPOSITION- Anonymous, "R&D Systems Catalog number MAB3552: Human BMP-2/BMP-4 Antibody", R&D Systems datasheet for anti-BMP-2/-4 antibody MAb3552, (20180702), pages 1 - 1, XP055813144-
OPPOSITION- Anonymous, "R&D Systems Datasheet Mab3552: Monoclonal Anti-human BMP-2/4 Antibody", R&D Systems Ordering Information Mab3552, (20050815), pages 1 - 2, XP055813147-
OPPOSITION- Anonymous, "R&D Systems Datasheet Mab507: Monoclonal Anti-human BMP-6 Antibody", R&D Systems Ordering Information, (20020409), pages 1 - 3, XP055813143-
OPPOSITION- Maes Ken, Et Al, "In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2", Blood, (20101104), vol. 116, no. 18, pages 3635 - 3644, XP055813128-
OPPOSITION- Zhang An-Sheng, Enns, Caroline A, "Iron Homeostasis: Recently Identified Proteins Provide Insight into Novel Control Mechanisms", The Journal of Biological Chemistry, (20091109), vol. 284, no. 2, pages 711 - 715, XP055813132-
OPPOSITION- HOLLIGER PHILIPP; HUDSON PETER J, "ENGINEERED ANTIBODY FRAGMENTS AND THE RISE OF SINGLE DOMAINS", Nature Biotechnology, New York, (20050901), vol. 23, no. 9, doi:10.1038/nbt1142, ISSN 1087-0156, pages 1126 - 1136, XP008076746
OPPOSITION- BABITT JODIE L ET AL, "Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression", Nature Genetics, New York, (20060501), vol. 38, no. 5, doi:10.1038/ng1777, ISSN 1061-4036, pages 531 - 539, XP002476347
OPPOSITION- Billy Andriopoulos Jr, Elena Corradini, Yin Xia, Sarah A Faasse, Shanzhuo Chen, Lovorka Grgurevic, Mitchell D Knutson, Antonello Pietrangelo, Slobodan Vukicevic, Herbert Y Lin & Jodie L Babitt, "BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism", Nature Genetics, New York, (20090401), vol. 41, no. 4, doi:10.1038/ng.335, ISSN 1061-4036, pages 482 - 487, XP008147148
OPPOSITION- BREKKE O H, SANDLIE I, "THERAPEUTIC ANTIBODIES FOR HUMAN DISEASES AT THE DAWN OF THE TWENTY-FIRST CENTURY.", Nature Reviews, GB, (20030101), vol. 2, doi:10.1038/nrd984, ISSN 1474-1784, pages 52 - 62, XP003009494
OPPOSITION- BABITT J L ET AL, "Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance", The Journal of Clinical Investigation, GB, (20070701), vol. 117, no. 7, doi:10.1172/JCI31342, ISSN 0021-9738, pages 1933 - 1939, XP002492455
OPPOSITION- Yin Xia, Jodie L. Babitt, Yisrael Sidis, Raymond T. Chung, and Herbert Y. Lin, "Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin", Blood, US, (20080515), vol. 111, no. 10, doi:10.1182/blood-2007-09-111567, ISSN 0006-4971, pages 5195 - 5204, XP008147144
OPPOSITION- L. Kautz et al, "Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver", Blood, (20080513), vol. 112, no. 4, doi:10.1182/blood-2008-03-143354, ISSN 00064971, pages 1503 - 1509, XP055065370
OTHER- KAUTZ L. ET AL, "Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver", BLOOD, (20080513), vol. 112, pages 1503 - 1509, XP055065370
SEARCH- CLARA CAMASCHELLA, "BMP6 orchestrates iron metabolism", NATURE METHODS, (20090301), vol. 41, no. 4, doi:10.1038/ng0409-386, ISSN 1548-7091, pages 386 - 388, XP055068868 [IP] 15-21,26-29 * the whole document *
SEARCH- DELPHINE MEYNARD ET AL, "Lack of the bone morphogenetic protein BMP6 induces massive iron overload", NATURE GENETICS, (20090301), vol. 41, no. 4, doi:10.1038/ng.320, ISSN 1061-4036, pages 478 - 481, XP055068872 [IP] 27,28 * the whole document *
SEARCH- BILLY ANDRIOPOULOS JR ET AL, "BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism", NATURE GENETICS, NATURE PUBLISHING GROUP, NEW YORK, US, vol. 41, no. 4, doi:10.1038/NG.335, ISSN 1061-4036, (20090301), pages 482 - 487, (20090301), XP008147148 [XP] 1-7,12-29 * the whole document *
SEARCH- BABITT J L ET AL, "Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance", JOURNAL OF CLINICAL INVESTIGATION, AMERICAN SOCIETY FOR CLINICAL INVESTIGATION, US, (20070701), vol. 117, no. 7, doi:10.1172/JCI31342, ISSN 0021-9738, pages 1933 - 1939, XP002492455 [X] 1-3,5-7,12-14 * the whole document * [I] 15-21,26-29

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents